Yashika Bansal
Research Subjects
Research Interests
Yashika Bansal has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Etienne Sibille
Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
2 shared publications - Sierra Codeluppi-Arrowsmith
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada
2 shared publications - Thomas Damien Prevot
Centre for Addiction and Mental Health
2 shared publications A.E. Lepack
Department of Psychiatry, Yale University
1 shared publication- Akiko Sumitomo
Centre for Addiction & Mental Health (CAMH), Toronto ON
1 shared publication - Brian J. Nieman
Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON M5T 3H7, Canada
1 shared publication
Latest Publications
- Open Access
The Aging Brain Matrix: Cross-Species Evidence Linking FREM3 to Brain and Cognitive Aging
The human extracellular-matrix-related FREM3 gene is strongly age-dependent, enriched in age- sensitive excitatory long-range-projecting neurons, and implicated in neurodegenerative diseases. To establish the first translationally relevant causal evidence for the gene’s roles in brain structure and cognition, we developed an excitatory-neuron-specific Frem3 conditional knockout mouse model ( Frem3 -cKO) and computed genetically regulated expression of FREM3 ( FREM3 - GReX) in humans, enabling convergent neurostructural and cognitive characterizations. Frem3 - cKO mice showed widespread lower global and regional brain volume in middle age vs young adulthood, consistent with drastic age-dependent volume loss absent in wildtype mice. These effects were strongest in cognitively relevant cortical regions and paralleled by lower cognitive performance. In humans, lower FREM3- GReX was associated with lower total surface area, which further mediated an indirect link to lower cognitive performance across multiple age- sensitive domains. We provide the first translationally relevant cross-species evidence supporting a key role for FREM3/Frem3 in maintaining brain and cognitive health across aging.
Open AccessThe Aging Brain Matrix: Cross-Species Evidence Linking FREM3 to Brain and Cognitive Aging
The human extracellular-matrix-related FREM3 gene is strongly age-dependent, enriched in age- sensitive excitatory long-range-projecting neurons, and implicated in neurodegenerative diseases. To establish the first translationally relevant causal evidence for the gene’s roles in brain structure and cognition, we developed an excitatory-neuron-specific Frem3 conditional knockout mouse model ( Frem3 -cKO) and computed genetically regulated expression of FREM3 ( FREM3 - GReX) in humans, enabling convergent neurostructural and cognitive characterizations. Frem3 - cKO mice showed widespread lower global and regional brain volume in middle age vs young adulthood, consistent with drastic age-dependent volume loss absent in wildtype mice. These effects were strongest in cognitively relevant cortical regions and paralleled by lower cognitive performance. In humans, lower FREM3- GReX was associated with lower total surface area, which further mediated an indirect link to lower cognitive performance across multiple age- sensitive domains. We provide the first translationally relevant cross-species evidence supporting a key role for FREM3/Frem3 in maintaining brain and cognitive health across aging.
- Open Access
Prefrontal Cortex Astroglia Modulate Anhedonia-like Behavior
Reductions of astroglia expressing glial fibrillary acidic protein (GFAP) are consistently found in the prefrontal cortex (PFC) of patients with depression and in rodent chronic stress models. Here, we examine the consequences of PFC GFAP+ cell depletion and cell activity enhancement on depressive-like behaviors in rodents. Using viral expression of diphtheria toxin receptor in PFC GFAP+ cells, which allows experimental depletion of these cells following diphtheria toxin administration, we demonstrated that PFC GFAP+ cell depletion induced anhedonia-like behavior within 2 days and lasting up to 8 days, but no anxiety-like deficits. Conversely, activating PFC GFAP+ cell activity for 3 weeks using designer receptor exclusively activated by designer drugs (DREADDs) reversed chronic restraint stress-induced anhedonia-like deficits, but not anxiety-like deficits. Our results highlight a critical role of cortical astroglia in the development of anhedonia and further support the idea of targeting astroglia for the treatment of depression.
Open AccessPrefrontal Cortex Astroglia Modulate Anhedonia-like Behavior
Reductions of astroglia expressing glial fibrillary acidic protein (GFAP) are consistently found in the prefrontal cortex (PFC) of patients with depression and in rodent chronic stress models. Here, we examine the consequences of PFC GFAP+ cell depletion and cell activity enhancement on depressive-like behaviors in rodents. Using viral expression of diphtheria toxin receptor in PFC GFAP+ cells, which allows experimental depletion of these cells following diphtheria toxin administration, we demonstrated that PFC GFAP+ cell depletion induced anhedonia-like behavior within 2 days and lasting up to 8 days, but no anxiety-like deficits. Conversely, activating PFC GFAP+ cell activity for 3 weeks using designer receptor exclusively activated by designer drugs (DREADDs) reversed chronic restraint stress-induced anhedonia-like deficits, but not anxiety-like deficits. Our results highlight a critical role of cortical astroglia in the development of anhedonia and further support the idea of targeting astroglia for the treatment of depression.
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S239-S240
P377. Chronic Restraint Stress Induces Prefrontal Cortex Astroglial Atrophy in Rodents
- 28 April 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (9) , S239-S240
P377. Chronic Restraint Stress Induces Prefrontal Cortex Astroglial Atrophy in Rodents